Eolus places order for 74 wind turbines, 279 MW with Vestas
Dec 29, 2017 13:30 pm UTC| Business
Eolus has signed an agreement with Vestas regarding delivery of 74 wind turbines of the model V136 with a capacity of 279 MW for four wind farms in Sweden. The wind turbines will be constructed in the wind farms...
Hemispherx Biopharma, Inc. to Present at Biotech Showcase™ 2018
Dec 29, 2017 13:30 pm UTC| Business
ORLANDO, Fla., Dec. 29, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB), focused on pharmaceutical research, today announced, that it will be presenting at the Biotech Showcase™ 2018. The conference will be held...
Dec 29, 2017 13:30 pm UTC| Business
NEW YORK, Dec. 29, 2017 -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that the U.S....
DSM and Amyris Close Transactions for Brazilian Production Facility
Dec 29, 2017 13:30 pm UTC| Business
HEERLEN, the Netherlands and EMERYVILLE, Calif., Dec. 29, 2017 -- Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc. (Nasdaq:AMRS), the industrial...
Nemus Bioscience Announces Closing of Convertible Bridge Loan and Anticipated Equity Financing
Dec 29, 2017 13:30 pm UTC| Business
COSTA MESA, Calif., Dec. 29, 2017 -- NEMUS Bioscience, Inc. (OTCQB: NMUS, “Nemus”) today announced that it entered into agreements with Emerald Health Sciences Inc. (“Emerald”), including a binding term sheet, Secured...
ECN Capital Closes the Acquisition of Triad Financial Services
Dec 29, 2017 13:12 pm UTC| Business
TORONTO, Dec. 29, 2017 -- ECN Capital Corp. (TSX:ECN) (“ECN Capital” or the “Company”), announced today that it has closed the acquisition of Triad Financial Services, Inc. (“Triad”) on the terms previously announced. ...
Pivot Initiates Development of Its First Cannabidiol Product with German Technology Partner
Dec 29, 2017 13:05 pm UTC| Business
VANCOUVER, British Columbia, Dec. 29, 2017 -- via NetworkNewsWire - Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that it has commenced development of PGS-N001...